Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Brain Injury Program
Cholesterol Lowering Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
17-Jan-2022
Change of Director's Interest Notice - CC
17-Jan-2022
Change of Director's Interest Notice - PM
12-Jan-2022
Nyrada Receives A$1.3M R&D Tax Incentive Rebate
4-Jan-2022
Brain Injury Program Update and Pathway to Phase I
22-Dec-2021
Cholesterol-Lowering Program Pathway to Phase I
10-Dec-2021
Release of Securities from Escrow
19-Nov-2021
Nyrada Annual General Meeting Results
19-Nov-2021
Annual General Meeting Presentation
19-Nov-2021
Nyrada AGM 2021 Chairman's Address
26-Oct-2021
Nyrada Quarterly Activities Report & Appendix 4C
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Next
